IMMUNOGENICITY AND SAFETY PROFILES OF GENETIC VACCINES AGAINST HUMAN HER-2/NEU IN CYNOMOLGUS MONKEYS

被引：0
|
作者：
Ko, Hyun-Jeong [1 ]
Kim, Yeon-Jeong [1 ]
Kim, Yun-Sun [1 ]
Kim, Jong-Mook [2 ]
Ho, Seong-Huyn [2 ]
Jeong, Jae-Gyun [2 ]
Oh, Sung-Min [2 ]
Chae, Jin-A [2 ]
Kim, Choong-Yong [3 ]
Lee, Pill Soo [3 ]
Kang, Chang-Yuil [1 ]
机构：
[1] Seoul Natl Univ, Coll Pharm, Inst Pharmaceut Sci, Immunol Lab, Seoul 151742, South Korea
[2] ViroMed Co Ltd, Seoul 151818, South Korea
[3] Korea Inst Toxicol, Div Nonclin Studies, Taejon 305600, South Korea
来源：
JOURNAL OF GENE MEDICINE | 2009年 / 11卷 / 12期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
引用
收藏
页码：1190 / 1190
页数：1
相关论文
共 50 条
  • [31] AMPLIFICATION OF HER-2/NEU ONCOGENE IN HUMAN OVARIAN-CANCER
    LEARY, JA
    EDWARDS, BG
    HOUGHTON, CRS
    KEFFORD, RF
    FRIEDLANDER, ML
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 1992, 2 (06) : 291 - 294
  • [32] EGF RECEPTOR AND HER-2/NEU IN HUMAN BREAST-CANCER
    WITTLIFF, JL
    WIEHLE, RD
    MARTIN, AW
    CLINICAL CHEMISTRY, 1990, 36 (06) : 1060 - 1060
  • [33] Peptide-based vaccination against the HER-2/neu oncogenic protein
    Boer R.
    Breast Cancer Research, 2 (1)
  • [34] Vaccination for the prevention and treatment of breast cancer with special focus on Her-2/neu peptide vaccines
    Wiedermann, Ursula
    Davis, Adam B.
    Zielinski, Christoph C.
    BREAST CANCER RESEARCH AND TREATMENT, 2013, 138 (01) : 1 - 12
  • [35] Vaccination for the prevention and treatment of breast cancer with special focus on Her-2/neu peptide vaccines
    Ursula Wiedermann
    Adam B. Davis
    Christoph C. Zielinski
    Breast Cancer Research and Treatment, 2013, 138 : 1 - 12
  • [36] Human ErbB-2 (Her-2) transgenic mice: A model system for testing Her-2 based vaccines
    Piechocki, MP
    Ho, YS
    Pilon, S
    Wei, WZ
    JOURNAL OF IMMUNOLOGY, 2003, 171 (11): : 5787 - 5794
  • [37] Genetic Regulation of the Response to Her-2 DNA Vaccination in Human Her-2 Transgenic Mice
    Radkevich-Brown, Olga
    Jacob, Jennifer
    Kershaw, Nfichael
    Wei, Wei-Zen
    CANCER RESEARCH, 2009, 69 (01) : 212 - 218
  • [38] Update on HER-2 as a target for cancer therapy: HER2/neu peptides as tumour vaccines for T cell recognition
    Isabel Correa
    Tim Plunkett
    Breast Cancer Research, 3
  • [39] Update on HER-2 as a target for cancer therapy - HER2/neu peptides as tumour vaccines for T cell recognition
    Correa, I
    Plunkett, T
    BREAST CANCER RESEARCH, 2001, 3 (06) : 399 - 403
  • [40] In the FVB/N HER-2/neu transgenic mouse both peripheral and central tolerance limit the immune response targeting HER-2/neu induced by Listeria monocytogenes-based vaccines
    Reshma, Singh
    Paterson, Yvonne
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2007, 56 (06) : 927 - 938
12345